- Prenatal ultrasound diagnosis of fetal maxillofacial teratom... 2024-08-29
- Successful cetuximab rechallenge in metastatic colorectal ca... 2024-08-29
- Periampullary duodenal neuroendocrine tumor in a patient wit... 2024-08-29
- Study on the expression and prognostic relationship of MYL6B... 2024-08-29
- Colorectal cancer: Recent advances in management and treatme... 2024-08-29
World Journal of Clinical Oncology (WJCO, World J Clin Oncol) is a high-quality, online, open-access, single-blind peer-reviewed journal published by the Baishideng Publishing Group. WJCO accepts both solicited and unsolicited manuscripts. Articles published in WJCO are high-quality, clinical and basic, influential research articles by established academic authors as well as new researchers. The paramount objective of WJCO is to showcase and promote distinguished research in the field of oncology, to help advance development of this field. The types of articles published in WJCO include Editorial, Opinion Review, Frontier, Review, Minireview, Clinical Research, Basic Study, Systematic Review, Meta-analysis, Evidence-based Medicine, Field of Vision, Clinical Guidelines, Letter to the Editor, and Case Report. Submit here >>
- Jian-Hua Mao, BSc, MSc, PhD, Adjunct Professor, Senior Scientist, (E-mail: [email protected]) Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, United States
- Hiten RH Patel, BM BCh, BSc, FRCS, PhD, Professor, Surgical Oncologist, (E-mail: [email protected]) Department of Urology, University Hospital North Norway, Tromso 9038, Norway
- Stephen Safe, PhD, Professor, (E-mail: [email protected]) Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX 77845, United States
- Ken H Young, MD, PhD, Chief Physician, Director, Full Professor, (E-mail: [email protected]) Hematopathology Division, Duke University Medical Center and Cancer Institute, Durham, NC 27710, United States
The 2024 edition of Journal Citation Reports® cites the 2023 journal impact factor (JIF) for WJCO as 2.6; JIF without journal self cites: 2.6; 5-year JIF: 2.7; JIF Rank: 175/322 in oncology; JIF Quartile: Q3; and 5-year JIF Quartile: Q3.
![](https://www.f6publishing.com/contents/images/coretip.png)
![](https://www.f6publishing.com/contents/images/coretip.png)
![](https://www.f6publishing.com/contents/images/coretip.png)
![](https://www.f6publishing.com/contents/images/coretip.png)
![](https://www.f6publishing.com/contents/images/coretip.png)